Literature DB >> 11520765

Effect of ABO blood group mismatching on corneal epithelial cells: an in vitro study.

J H Chan1, H S Dua, A Powell-Richards, D R Jones, I M Harris.   

Abstract

AIM: To determine, in vitro, the effects of blood group ABO mismatching on corneal epithelial cells.
METHODS: Corneal epithelial cell cultures were established from 32 human cadaver donor eyes. Epithelial cells (100 microl of 4 x 10(2) cells per microl) were incubated for 4 hours with antibodies against blood group antigens A, B, and AB, with and without complement. Cell lysis was assayed by a chemiluminescent assay using Cytolite reagent. Live cells, remaining after incubation, were counted in a scintillation counter. The blood group of the donors was determined retrospectively, in a blinded manner.
RESULTS: Retrospective tracing of donor blood groups was possible for 20 donors. In all cases the blood group corresponded with that suggested by the cell lysis assay. Significant cell lysis was observed when known A group cells were incubated with anti-A and anti-AB antibody, B group cells were incubated with anti-B and AB antibody, and AB group cells were incubated with anti-AB antibody. Lysis occurred only in the presence of complement. No lysis of O group cells was observed with any of the antibodies. In all cases, lysis was observed only with neat (serum) antibody concentrations.
CONCLUSIONS: Blood group ABO mismatching results in significant lysis of corneal epithelial cells. The antibody concentration required for lysis equals that found in serum. Such levels of antibody are unlikely to be achieved in tears and/or aqueous. This may offer an explanation for the conflicting reports of the studies on the effect of blood group matching on corneal grafts. The variability in the outcome may reflect the levels of antibodies gaining access to the corneal cells and not the mismatching alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520765      PMCID: PMC1724101          DOI: 10.1136/bjo.85.9.1104

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Corneal transplants and blood types; a clinical study.

Authors:  P MEHRI; B BECKER; R OGLESBY
Journal:  Am J Ophthalmol       Date:  1959-01       Impact factor: 5.258

2.  Application of specific red blood cell adherence test to the human cornea and conjunctiva.

Authors:  H S Dua; V B Shidham
Journal:  Am J Ophthalmol       Date:  1979-12       Impact factor: 5.258

3.  Immunoglobulins in tears.

Authors:  B H McClellan; C R Whitney; L P Newman; M R Allansmith
Journal:  Am J Ophthalmol       Date:  1973-07       Impact factor: 5.258

4.  Regulators of immunological responses in the cornea and the anterior chamber of the eye.

Authors:  M J Jager; D S Gregerson; J W Streilein
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

Review 5.  Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.

Authors:  J W Streilein
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

6.  The effect of prospective HLA-A and -B matching on corneal graft survival.

Authors:  H J Völker-Dieben; C C Kok-van Alphen; Q Lansbergen; G G Persijn
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-04

7.  Role of ABO and Lewis blood group antigens in donor-recipient compatibility of corneal transplantation rejection.

Authors:  R Roy; B Des Marchais; R Bazin; H M Boisjoly; I Dubé; P A Laughrea
Journal:  Ophthalmology       Date:  1997-03       Impact factor: 12.079

8.  The distribution of HLA antigens on human corneal tissue.

Authors:  C F Whitsett; R D Stulting
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-05       Impact factor: 4.799

9.  HLA matching and corneal grafting.

Authors:  J R Batchelor; T A Casey; A Werb; D C Gibbs; S S Prasad; D F Lloyd; A James
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

10.  Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection.

Authors:  S M Nicholls; B B Bradley; D L Easty
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-09       Impact factor: 4.799

View more
  2 in total

Review 1.  No time to lose--high throughput screening to assess nanomaterial safety.

Authors:  R Damoiseaux; S George; M Li; S Pokhrel; Z Ji; B France; T Xia; E Suarez; R Rallo; L Mädler; Y Cohen; E M V Hoek; A Nel
Journal:  Nanoscale       Date:  2011-02-07       Impact factor: 7.790

Review 2.  Immunological barriers to stem-cell based cardiac repair.

Authors:  Zaruhi Karabekian; Nikki Gillum Posnack; Narine Sarvazyan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.